Maintenance decisions get made on gut feel and renewal deadlines. ClaimHit gives you the missing input: for each asset, who is actually practising it in the market right now, and how well that can be evidenced.
Run the portfolio, not a sample. Each patent gets the same pipeline, so the comparison across assets is like-for-like.
Turn on monitoring per asset and set the cadence — daily through quarterly. New matches trigger an email rather than waiting for the next review cycle.
Claim coverage is weighted by position: inventive limitations count for more than preamble scaffolding. A target that meets the boilerplate and misses the invention is reported as exactly that.
Check whether an asset reads on the mandatory provisions of a technical standard — read from the specification itself, not a summary of it.
Candidates come from several models, live web and neural search, forward citations, and the authoritative registries for the field — but breadth only widens the net. Each one is still checked against real, citable evidence, and anything that cannot be evidenced is dropped rather than shown with a caveat. See every source →
Start with the assets whose renewals are closest. The decisions with a deadline benefit most from evidence.
Apply for Beta Access →